LUNDBECK SELECTS SWIXX AS A KEY PARTNER IN A TRANSFORMATIVE MULTI-REGIONAL DEAL

Swixx BioPharma United Kingdom England Switzerland Turkey Israel Russia United States of America Latin America

Partnership spans three regions, positioning Swixx as a strong player in CNS therapy area Builds on global pharma trend of outsourcing access and commercialization in the emerging marketsUnderscores Swixx scale in Latam and leverages Swixx entry into Israeli and Turkish markets View original content:https://www.prnewswire.co.uk/news-releases/lundbeck-selects-swixx-as-a-key-partner-in-a-transformative-multi-regional-deal-302551183.html